Kymera Therapeutics Inc. logo

Kymera Therapeutics Inc.

KYMR | NASDAQ
Chart Builder DCF Calculator
$120.75
+$3.08 (+2.62%)
Sep 22, 2026, 12:06 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
357.01M 120.26M 109.97M 68.4M 47.98M 31M
Short-Term Investments
491.27M 368.49M 264.92M 338.77M 394.44M 265.2M
Long-Term Investments
776.96M 362.16M 61.43M 152.33M 125.19M 162.53M
Other Long-Term Assets
9.11M 7.74M 7.93M 9.15M 8.14M 1.62M
Receivables
n/a 947K 18.76M 2.54M 135K 1.43M
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
22.94M 20.58M 11.67M 9.71M n/a n/a
Total Current Assets
871.21M 510.27M 405.32M 419.42M 451.27M 302.34M
Property-Plant & Equipment
85.53M 97.86M 101.08M 22.24M 21.31M 20.69M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
871.6M 467.77M 170.44M 183.72M 154.63M 184.84M
Total Assets
1.74B 978.04M 575.76M 603.13M 605.91M 487.18M
Account Payables
4.01M 5.99M 7.08M 4.34M 4.01M 4.37M
Deferred Revenue
22.93M 13.58M 37.88M 35.26M 61.74M 92.55M
Short-Term Debt
13.76M n/a n/a n/a n/a n/a
Other Current Liabilities
24.21M 223K 23.16M 303K 228K 106K
Total Current Liabilities
83.21M 67.77M 85.69M 71.34M 92.54M 110.62M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a 248K 66K 100K
Total Long-Term Liabilities
79.94M 74.65M 95.1M 41.64M 53.73M 92.67M
Total Liabilities
163.15M 142.42M 180.79M 112.98M 146.27M 203.29M
Total Debt
82.25M 87.76M 84.67M 17.34M 17.96M 17.99M
Book Value
1.58B 835.62M 394.97M 490.15M 459.64M 283.89M
Book Value Per Share
18.72 11.14 6.77 9.09 9.58 6.37
Common Stock
8K 7K 6K 6K 5K 4K
Retained Earnings
-1.07B -754.61M -530.75M -383.79M -228.98M -128.77M
Comprehensive Income
1.8M -1.49M -552K -4.95M -660K -128K
Shareholders Equity
1.58B 835.62M 394.97M 490.15M 459.64M 283.89M
Total Investments
1.27B 730.65M 326.35M 491.1M 519.63M 427.73M

© 2026 bestshares.com. All rights reserved.